The first test

Genetic testing for Huntingdon's disease by insurance companies is to be sanctioned by UK ministers this week. Opposition to this decision by members of parliament and consumer groups raised concerns that DNA testing for insurance purposes would create a 'genetic underclass' of people unable to gain cover, or having to pay higher premiums. People would be forced to disclose the results of a DNA test or risk rendering their cover null or void.A spokeswoman for the National Consumer Council warned

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Genetic testing for Huntingdon's disease by insurance companies is to be sanctioned by UK ministers this week. Opposition to this decision by members of parliament and consumer groups raised concerns that DNA testing for insurance purposes would create a 'genetic underclass' of people unable to gain cover, or having to pay higher premiums. People would be forced to disclose the results of a DNA test or risk rendering their cover null or void.

A spokeswoman for the National Consumer Council warned: "This could discourage people from taking a test, which may be in their interest. It may stop them from gaining early diagnosis for treatable illnesses." The insurance industry will be instructed that it can only use genetic tests for Huntingdon's to assess life insurance cover, but not mortgage protection or other insurance.

To evaluate genetic testing, the Department of Health has set up a Genetics and Insurance Committee: an ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control